Comparison between Aptus Pharma IPO and Prime Cable Industries IPO.
Aptus Pharma IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Prime Cable Industries IPO is a SME Bookbuilding proposed to list at NSE SME.
| Aptus Pharma IPO | Prime Cable Industries IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Interactive Financial Services Ltd. | Indorient Financial Services Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Market-Hub Stock Broking Pvt.Ltd. | Alacrity Securities Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Aptus Pharma IPO is up to ₹12.36 Cr whereas the issue size of the Prime Cable Industries IPO is up to ₹38.03 Cr. The final issue price of Aptus Pharma IPO is ₹70.00 per share and of Prime Cable Industries IPO is ₹83.00 per share.
| Aptus Pharma IPO | Prime Cable Industries IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹5 per share |
| Issue Price (Lower) | ₹65.00 per share | ₹78.00 per share |
| Issue Price (Upper) | ₹70.00 per share | ₹83.00 per share |
| Issue Price (Final) | ₹70.00 per share | ₹83.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 1600 shares |
| Fresh Issue Size | 17,66,000 shares | 39,80,800 shares |
| Fresh Issue Size (Amount) | up to ₹12.36 Cr | up to ₹33.04 Cr |
| OFS Issue Size | 0 shares | 6,01,600 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹4.99 Cr |
| Issue Size Total | 17,66,000 shares | 45,82,400 shares |
| Issue Size Total (Amount) | up to ₹12.36 Cr | up to ₹38.03 Cr |
Aptus Pharma IPO opens on Sep 23, 2025, while Prime Cable Industries IPO opens on Sep 22, 2025. The closing date of Aptus Pharma IPO and Prime Cable Industries IPO is Sep 25, 2025, and Sep 24, 2025, respectively.
| Aptus Pharma IPO | Prime Cable Industries IPO | |
|---|---|---|
| Anchor Bid Date | Sep 22, 2025 | Sep 19, 2025 |
| Issue Open | Sep 23, 2025 | Sep 22, 2025 |
| Issue Close | Sep 25, 2025 | Sep 24, 2025 |
| Basis Of Allotment (Tentative) | Sep 26, 2025 | Sep 25, 2025 |
| Initiation of Refunds (Tentative) | Sep 29, 2025 | Sep 26, 2025 |
| Credit of Share (Tentative) | Sep 29, 2025 | Sep 26, 2025 |
| Listing date (Tentative) | Sep 30, 2025 | Sep 29, 2025 |
| Anchor Lockin End date 1 | Oct 26, 2025 | Oct 25, 2025 |
| Anchor Lockin End date 2 | Dec 25, 2025 | Dec 24, 2025 |
Aptus Pharma IPO P/E ratio is 11.29, as compared to Prime Cable Industries IPO P/E ratio of 15.6.
| Aptus Pharma IPO | Prime Cable Industries IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Aptus Pharma Ltd.'s revenue increased by 38% and profit after tax (PAT) rose by 288% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Prime Cable Industries Ltd.'s revenue increased by 71% and profit after tax (PAT) rose by 319% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 92.93 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 72.89 | 68.24 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 11.29 | 15.6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹48.02 Cr. | ₹152.06 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 44.50% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 45.66% | 25.96% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.49 | 2.63 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹6.20 | ₹5.32 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 44.50% | 69.16% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Aptus Pharma IPO Retail Individual Investors (RII) are offered 6,20,000 shares while in Prime Cable Industries IPO retail investors are offered 6,20,000 shares. Qualified Institutional Buyers (QIB) are offered 3,52,000 shares in Aptus Pharma IPO and 9,15,200 shares in Prime Cable Industries IPO.
| Aptus Pharma IPO | Prime Cable Industries IPO | |
|---|---|---|
| Anchor Investor Reservation | 5,28,000 shares | 13,72,800 shares |
| Market Maker Reservation | 94,000 shares | 2,41,600 shares |
| QIB | 3,52,000 shares | 9,15,200 shares |
| NII | 2,66,000 shares | 6,88,000 shares |
| RII | 6,20,000 shares | 16,06,400 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 17,66,000 shares | 45,82,400 shares |
Aptus Pharma IPO subscribed 22.27x in total, whereas Prime Cable Industries IPO subscribed 8.28x.
| Aptus Pharma IPO | Prime Cable Industries IPO | |
|---|---|---|
| QIB (times) | 1.24x | 9.91x |
| NII (times) | 28.75x | 9.38x |
| Big NII (times) | 30.64x | 10.49x |
| Small NII (times) | 24.93x | 7.15x |
| RII (times) | 31.43x | 6.89x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 22.27x | 8.28x |
